Long Acting Insulin Versus Multiple Dose Regimen for Control of Gestational Diabetes Mellitus

Ain Shams University

Status and phase: Completed; Phase 3; Phase 2

Conditions: Long Acting Insulin in Control of Gestational Diabetes Mellitus

Treatments: Drug: Long acting insulin; Drug: multiple dose regimen

Study type: Interventional

Funder types: Other

Identifiers

NCT04674332

323/2019

Details and patient eligibility

About

multiple dose regimen as a standard treatment for gestational diabetes will be compared to long acting insulin

Enrollment: 148 patients

Sex: Female

Ages: 18 to 45 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• pregnant women with gestational diabetes mellitus
• between 24-28 weeks gestation

Exclusion criteria

• other endocrinological abnormalities

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

148 participants in 2 patient groups

long acting insulin

Experimental group

Treatment:

Drug: Long acting insulin

multiple dose regimen

Active Comparator group

Treatment:

Drug: multiple dose regimen